Eluvia™ Drug-Eluting Vascular Stent System
Designed with sustained release to match the restenotic process of the SFA. Eluvia demonstrated superiority at 1-Year in two RCTS - bare metal stents in EMINENT2 and Zilver PTX in IMPERIAL3. No SFA stent has performed better at 2-Years. No matter the lesion complexity. No matter the patient.
Ranger™ Drug-Coated Balloon
Ranger DCB is built on the physician preferred Sterling™ 0.014”/0.018" balloon platform4 with a low entry profile and backed by clinical results which demonstrate consistent near 90% patency at 1-Year5 and exceptional outcomes at 2 years6.
Explore DE Resources
Get physician perspectives, clinical data sheets and other resources about drug-eluting innovations.
Stay Up to Date
Receive emails about the latest drug-eluting technology news, innovations and events in your area.